About
Acutus is focused on the production of left-heart access products under its distribution agreement with
Investor Contact: |
D: 442-232-6080 |
investors@acutus.com |
Source:
2023 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0481 USD | +17.32% | -46.56% | -76.18% |
13/05 | Acutus Medical, Inc.(NasdaqCM:AFIB) dropped from S&P TMI Index | CI |
09/05 | Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Continuing Operations Revenue $3.6M | MT |
About
Acutus is focused on the production of left-heart access products under its distribution agreement with
Investor Contact: |
D: 442-232-6080 |
investors@acutus.com |
Source:
2023 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-76.18% | 12.19L | |
+10.86% | 12TCr | |
-5.42% | 1.12TCr | |
+4.17% | 916.62Cr | |
-21.47% | 471.19Cr | |
+8.77% | 344.12Cr | |
-6.03% | 287.97Cr | |
-12.05% | 211.11Cr | |
-7.83% | 209.29Cr | |
-22.84% | 179.8Cr |